Search research articles
Contact Us
Filters
Showing results (1-10 of 60) with videos related to
Page
of 6
Sort By:
Lancet (London, England)
|
April 16, 2017
NSAIDs for high-risk patients: none, celecoxib, or naproxen?
Patricia McGettigan, Anne-Marie Schjerning Olsen
Nature Reviews. Cardiology
|
April 24, 2020
Cardiovascular effects and safety of (non-aspirin) NSAIDs
Anne-Marie Schjerning, Patricia McGettigan, Gunnar Gislason
Ugeskrift for Laeger
|
September 5, 2014
[In Process Citation]
Anne-Marie Schjerning Olsen, Espen Jimenez-Solem
Ugeskrift for Laeger
|
April 16, 2013
[Pharmacoepidemiology--rational use of drugs]
Christian Fynbo Christiansen, Anne-Marie Schjerning Olsen
Ugeskrift for Laeger
|
November 12, 2024
Christopher Ryan Zörner, Ann Banke, Anne-Marie Schjerning
Nature Reviews. Cardiology
|
May 31, 2020
Reply to 'Aspirin as a painkiller in patients with a high cardiovascular risk profile'
Anne-Marie Schjerning, Patricia McGettigan, Gunnar H Gislason
Current Opinion in Cardiology
|
October 1, 2013
Time-perspective in cardiovascular risk of NSAID use after first-time myocardial infarction
Anne-Marie Schjerning Olsen, Gunnar H Gislason, Emil L Fosbøl
Basic & Clinical Pharmacology & Toxicology
|
April 3, 2014
The impact of NSAID treatment on cardiovascular risk - insight from Danish observational data
Anne-Marie Schjerning Olsen, Emil L Fosbøl, Gunnar H Gislason
European Heart Journal. Cardiovascular Pharmacotherapy
|
April 27, 2017
Coronary artery disease severity and long-term cardiovascular risk in patients with myocardial infarction: a Danish nationwide register-based cohort study
Cengiz Özcan, Anna Deleskog, Anne-Marie Schjerning Olsen, et al.
Ugeskrift for Laeger
|
January 3, 2017
[Cardiovascular risks of non-steroidal anti-inflammatory drugs treatment]
Morten Schmidt, Emil Loldrup Fosbøl, Christian Torp-Pedersen, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 60) with videos related to
Sort By:
Page
of 6
Lancet (London, England)
|
April 16, 2017
NSAIDs for high-risk patients: none, celecoxib, or naproxen?
Patricia McGettigan, Anne-Marie Schjerning Olsen
Nature Reviews. Cardiology
|
April 24, 2020
Cardiovascular effects and safety of (non-aspirin) NSAIDs
Anne-Marie Schjerning, Patricia McGettigan, Gunnar Gislason
Ugeskrift for Laeger
|
September 5, 2014
[In Process Citation]
Anne-Marie Schjerning Olsen, Espen Jimenez-Solem
Ugeskrift for Laeger
|
April 16, 2013
[Pharmacoepidemiology--rational use of drugs]
Christian Fynbo Christiansen, Anne-Marie Schjerning Olsen
Ugeskrift for Laeger
|
November 12, 2024
Christopher Ryan Zörner, Ann Banke, Anne-Marie Schjerning
Nature Reviews. Cardiology
|
May 31, 2020
Reply to 'Aspirin as a painkiller in patients with a high cardiovascular risk profile'
Anne-Marie Schjerning, Patricia McGettigan, Gunnar H Gislason
Current Opinion in Cardiology
|
October 1, 2013
Time-perspective in cardiovascular risk of NSAID use after first-time myocardial infarction
Anne-Marie Schjerning Olsen, Gunnar H Gislason, Emil L Fosbøl
Basic & Clinical Pharmacology & Toxicology
|
April 3, 2014
The impact of NSAID treatment on cardiovascular risk - insight from Danish observational data
Anne-Marie Schjerning Olsen, Emil L Fosbøl, Gunnar H Gislason
European Heart Journal. Cardiovascular Pharmacotherapy
|
April 27, 2017
Coronary artery disease severity and long-term cardiovascular risk in patients with myocardial infarction: a Danish nationwide register-based cohort study
Cengiz Özcan, Anna Deleskog, Anne-Marie Schjerning Olsen, et al.
Ugeskrift for Laeger
|
January 3, 2017
[Cardiovascular risks of non-steroidal anti-inflammatory drugs treatment]
Morten Schmidt, Emil Loldrup Fosbøl, Christian Torp-Pedersen, et al.
Page
of 6